Information Provided By: 
Fly News Breaks for July 13, 2015
EW
Jul 13, 2015 | 08:41 EDT
Northland upgraded Edwards Lifesciences to Outperform citing the acquisition of CardiAQ, an early-stage company developing a TMVI system. The firm views the acquisition as a smart as it jump starts the TMVI program and adds a wealth knowledge from the principals who have a prior background at CoreValue. Northland increased Edwards Lifesciences' price target to $170 from $140 on shares.
News For EW From the Last 2 Days
